ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
33
views
0
references
Top references
cited by
43
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,298
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Author(s):
Mathew Martin
,
Sanne H Olesen
,
Gunda Georg
,
Ernst Schonbrunn
Publication date:
2013-09-23
Journal:
ACS Chemical Biology
Publisher:
American Chemical Society (ACS)
Read this article at
ScienceOpen
Publisher
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
IODP Expedition 378: South Pacific Paleogene Climate
Author and article information
Journal
DOI::
10.1021/cb4003283
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,298
Dinaciclib (SCH727665) inhibits the unfolded protein response (UPR) through a CDK1 and CDK5-dependent mechanism
Authors:
TK Nguyen
,
S Grant
A phase 3 study to evaluate the efficacy and safety of dinaciclib compared to ofatumumab in patients with refractory chronic lymphocytic leukemia
Authors:
P. Ghia
,
L Scarfo
,
K Pathiraja
Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib
Authors:
Shahin Hallaj
,
Sima Heydarzadeh Asl
,
Fatemeh Alian
…
See all similar
Cited by
42
Bromodomains: a new target class for drug development
Authors:
Andrea Cochran
,
Andrew Conery
,
Robert Sims
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Authors:
Ali Alqahtani
,
Khalil Choucair
,
Mushtaq Ashraf
…
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Authors:
Pietro Ciceri
,
Susanne Müller
,
Alison O’Mahony
…
See all cited by
Version 1
Version 1